For many employers, the cost of specialty medications represents 50% of their total drug spend, and over the next two years, nearly two-thirds of new drug launches are expected to be specialty therapies. This dynamic creates a daunting challenge to plan sponsors who are looking to provide the best, potentially life-changing medicines to their employees and also manage the cost of their pharmacy benefits. To that end, it's imperative that plan sponsors have strategies in place to control specialty costs while ensuring their members have access to the right prescriptions. During this interactive virtual session, Truveris experts will uncover the market dynamics that are contributing to the continual rise of specialty costs - and most importantly, what plan sponsors can do about it.
Thu, May 13, 2021 · 12:00 PM Eastern Time (US & Canada) (GMT -4:00)
  • How market dynamics are affecting specialty costs
  • What the key considerations are while addressing specialty costs
  • What options are available to plan sponsors to manage specialty
Heidi Chinwuba, PharmD, BCPS, BCACP
Client Services Director, Truveris
Heidi is a pharmacy benefit manager (PBM) subject matter expert with over 15 years experience as a clinician. Heidi serves as strategic member of Truveris’ account management team providing consultative and clinical insights to help clients optimize their pharmacy benefits.

She is passionate about helping clients achieve quality health outcomes through appropriate use of medications, while maintaining and advocating for affordability. Prior to Truveris, she worked in various clinical and leadership roles at Providence St. Joseph Health. Most recently, as a Clinical Account Manager at Providence Health Plan, she was responsible for partnering with public and private sector groups of all sizes to ensure the end-to-end pharmacy benefit management cycle. She also has experience providing direct patient care.

Heidi received her Doctor of Pharmacy from the University of Montana, completed a managed care residency at Kaiser Permanente, and holds dual board certification in pharmacotherapy and ambulatory care.